Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.81%66B | 0.79%62.97B | -0.61%15.52B | -0.68%16.22B | 1.37%15.62B | 3.24%15.62B | 7.53%62.48B | 4.42%15.62B | 10.11%16.33B | 8.94%15.41B |
| Cost of revenue | 4.14%61.18B | 0.31%58.75B | -0.10%14.57B | -1.81%15.02B | 0.87%14.67B | 2.45%14.49B | 7.57%58.57B | 4.35%14.59B | 10.77%15.29B | 9.37%14.55B |
| Gross profit | 14.20%4.82B | 8.05%4.22B | -7.80%948.46M | 16.10%1.2B | 9.80%945.36M | 14.67%1.12B | 6.91%3.9B | 5.41%1.03B | 1.15%1.03B | 2.19%860.97M |
| Operating expense | 12.09%3.59B | 11.83%3.2B | 16.09%784.69M | 11.23%816.63M | 9.20%806.09M | 11.12%793.57M | 9.16%2.86B | 5.37%675.92M | 14.01%734.18M | 11.09%738.17M |
| Staff costs | 8.21%2.06B | 9.42%1.91B | 9.25%451.5M | 9.63%480.78M | 10.77%496.32M | 8.00%477.1M | 6.60%1.74B | 6.02%413.27M | 9.94%438.53M | 6.49%448.07M |
| Selling and administrative expenses | 15.34%949.87M | 23.63%823.55M | ---- | ---- | ---- | ---- | 15.48%666.13M | ---- | ---- | ---- |
| -Selling and marketing expense | 12.63%23.52M | -1.55%20.88M | ---- | ---- | ---- | ---- | 14.37%21.21M | ---- | ---- | ---- |
| -General and administrative expense | 15.41%926.35M | 24.46%802.67M | ---- | ---- | ---- | ---- | 15.52%644.91M | ---- | ---- | ---- |
| Depreciation and amortization | 143.87%181.58M | 28.99%74.46M | ---- | ---- | ---- | ---- | -1.40%57.72M | ---- | ---- | ---- |
| -Depreciation | 143.87%181.58M | 28.99%74.46M | ---- | ---- | ---- | ---- | -1.40%57.72M | ---- | ---- | ---- |
| Other operating expenses | -0.70%394.47M | 0.08%397.27M | -22.47%-564.82M | 13.60%335.84M | 6.78%309.77M | 16.18%316.47M | 12.44%396.94M | -20.20%-461.2M | 20.64%295.64M | 19.02%290.11M |
| Operating profit | 20.81%1.23B | -2.32%1.02B | -53.58%163.77M | 27.99%384.55M | 13.41%139.27M | 24.23%329.7M | 1.17%1.04B | 5.47%352.81M | -20.71%300.46M | -31.02%122.8M |
| Net non-operating interest income (expenses) | -8.55%-175.95M | -18.87%-162.1M | -40.59%-48.75M | -8.38%-38.66M | -6.75%-36.53M | -20.00%-38.16M | -4.36%-136.37M | -13.80%-34.68M | -10.72%-35.67M | -2.24%-34.22M |
| Non-operating interest income | 9.03%26.02M | 35.54%23.87M | -3.36%6.42M | 60.75%5.16M | 113.57%7.26M | 15.41%5.03M | 35.98%17.61M | 29.06%6.64M | 0.69%3.21M | 17.21%3.4M |
| Non-operating interest expense | 15.36%201.98M | 13.71%175.09M | 7.20%44.29M | 12.70%43.82M | 16.40%43.79M | 19.45%43.2M | 7.21%153.98M | 16.00%41.32M | 9.82%38.88M | 3.43%37.62M |
| Total other finance cost | ---- | --10.88M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | 9.58%18.25M | -40.89%16.65M | 2,051.87%14.93M | -277.70%-7.15M | -50.09%13.97M | -12.44%-5.11M | 47.22%28.17M | 167.97%694K | 4,178.72%4.02M | 184.37%28M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -21.31%30.3M | 932.77%38.51M | -101.16%-192K | 2,045.78%14.07M | 180.72%11.28M | 632.24%13.36M | -94.14%3.73M | -17.79%16.6M | -104.14%-723K | -215.89%-13.97M |
| Special income (charges) | -598.15%-311.57M | 51.68%-44.63M | 264.11%147.18M | -1,453.20%-145.23M | 120.09%1.87M | -1,075.95%-48.45M | -1,341.85%-92.37M | -81.43%-89.68M | 6.32%10.73M | -308.84%-9.3M |
| Less:Other special charges | -1,656.87%-218.57M | 77.87%-12.44M | -565.83%-188.84M | 1,345.30%133.65M | 44.68%-5.69M | 809.04%48.45M | 33.52%-56.22M | 31.71%-28.36M | -6.32%-10.73M | -552.51%-10.29M |
| Less:Write off | 828.95%530.14M | -61.59%57.07M | -64.70%41.67M | --11.58M | -80.48%3.82M | --0 | 63.35%148.58M | --118.04M | --0 | --19.59M |
| Other non-operating income (expenses) | -49.42%34.95M | 22.20%69.1M | 221.89%26.12M | 52.67%29.69M | -121.94%-2.67M | -5.23%15.95M | -15.80%56.55M | -38.83%8.12M | 33.86%19.45M | -56.41%12.15M |
| Income before tax | -11.75%824.95M | 3.73%934.81M | 23.49%303.05M | -22.64%237.28M | 20.62%127.19M | 9.73%267.29M | -13.23%901.18M | -13.39%245.4M | -21.12%306.73M | -45.09%105.45M |
| Income tax | -18.43%356.83M | 19.63%437.44M | 60.79%143.48M | 8.12%116.45M | 10.92%70.55M | 1.75%106.95M | -6.83%365.66M | -0.59%89.23M | -20.44%107.71M | -26.98%63.61M |
| Net income | -5.88%468.13M | -7.12%497.38M | 2.18%159.57M | -39.29%120.83M | 35.36%56.64M | 15.78%160.34M | -17.12%535.52M | -19.33%156.17M | -21.49%199.03M | -60.13%41.84M |
| Net income continuous operations | -5.88%468.13M | -7.12%497.38M | 2.18%159.57M | -39.29%120.83M | 35.36%56.64M | 15.78%160.34M | -17.12%535.52M | -19.32%156.17M | -21.49%199.02M | -60.13%41.84M |
| Noncontrolling interests | 411.76%6.89M | -118.51%-2.21M | -144.99%-1.03M | -284.52%-4.08M | -61.79%1.97M | -59.45%929K | -11.06%11.94M | -1.63%2.29M | -12.48%2.21M | 4.89%5.15M |
| Net income attributable to the company | -7.68%461.24M | -4.58%499.59M | 4.37%160.6M | -36.54%124.9M | 49.01%54.67M | 17.04%159.41M | -17.25%523.58M | -19.54%153.88M | -21.58%196.82M | -63.32%36.69M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -7.68%461.24M | -4.58%499.59M | 4.37%160.6M | -36.54%124.9M | 49.01%54.67M | 17.04%159.41M | -17.25%523.58M | -19.54%153.88M | -21.58%196.82M | -63.32%36.69M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -6.84%340.58 | -4.45%365.6 | 4.80%117.86 | -36.54%91.28 | 49.05%39.96 | 17.04%116.5 | -17.25%382.64 | -19.54%112.46 | -21.58%143.83 | -63.32%26.81 |
| Diluted earnings per share | -6.84%340.58 | -4.45%365.6 | 4.81%117.86 | -36.54%91.28 | 49.03%39.9552 | 17.04%116.5 | -17.25%382.64 | -19.54%112.4565 | -21.58%143.83 | -63.32%26.81 |
| Dividend per share | 0.00%80 | 0.00%80 | 0.00%40 | 0 | 0.00%40 | 0 | 0.00%80 | 0.00%40 | 0 | 0.00%40 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |